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The IL-36 subfamily is a recently described group of cytokines with pro-inflammatory 
behavior, comprising three agonists (α, β, and γ), its receptor (R), and one antagonist 
(Ra). The expression and function of IL-36 subfamily members in the estrous cycle in 
healthy and infected pregnancy has not been described. We evaluated mRNA and 
protein expression of IL-36 family members during the estrous cycle, implantation, fetal 
development, and post-labor periods in a model of allogenic pregnancy in mice. We 
also explored the ability of Listeria monocytogenes to modulate the expression of IL-36 
subfamily members during pregnancy. Expression of IL-36 subfamily members showed 
different expression during the estrous cycle and pregnancy but was induced at estrous, 
16.5 days post coitum (dpc), 18.5 dpc, and labor. IL-36 subfamily members showed 
a characteristic distribution in the glandular epithelium, perimetrium, myometrium, and 
stratum vasculare. Infection with L. monocytogenes during pregnancy induced strong 
production of IL-36 subfamily members, an observation that correlated with an increasing 
prevalence of fetal loss. In conclusion, IL-36 agonists showed specific patterns of mRNA 
and protein expression that might suggest functional specialization or specific target 
cells. Infection with L. monocytogenes during pregnancy induced strong production of 
IL-36 subfamily members.
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inTrODUcTiOn
The menstrual cycle in humans, as well as the estrous cycle in rodents, prepares females for repro-
duction (1). Establishment of pregnancy requires a finely balanced interaction between the embryo 
and maternal tissue that is mediated by hormones and cytokines (2). Several studies in mammals 
have shown that inflammation is crucial at the maternal–fetal interface, both at implantation and 
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at parturition (3, 4). During implantation and placentation, 
the uterus must be modified to accept the graft. Such tissue 
remodeling is orchestrated by the activity of several cytokines 
and chemokines arising from uterine natural killer cells, mac-
rophages, dendritic cells (DCs), and non-immune uterine cells 
(4). In health, labor is predicated to be an inflammatory event 
because of increased leukocyte infiltrates and the production of 
pro-inflammatory molecules in the uterus (5). Leukemia inhibi-
tory factor (LIF), IL-6, TNF-α, and IL-1β have been described 
as the main participants in inflammation during the events 
cited above. Other molecules of the IL-1 family (IL-1α, IL-18, 
IL-1R1, IL-1RA, IL-1RAcP, and ST2L) and molecules associated 
with inflammasomes (NLRP-1, NLRP-3, NLRC-4, caspase I, 
and ASC) have been reported to be active in early pregnancy, 
parturition, preterm labor, preeclampsia, and infection during 
pregnancy (3, 4, 6).
Members of the IL-1 subfamily, such as IL-36α (IL-1F6), 
IL-36β (IL-1F8), IL-36γ (IL-1F9), IL-36R (IL-1Rrp2), and the 
receptor antagonist IL-36Ra (IL-1F5) constitute a novel signal-
ing system that has not been studied in depth in the normal 
inflammatory process of pregnancy, or in pregnant women with 
a bacterial infection.
There is evidence of IL-36 involvement in the innate and adap-
tive immunity associated with inflammation enhancement in the 
skin, kidney, joints, brain, and lung, where keratinocytes, CD4+ 
T cells, DCs, and macrophages can be a source of members of the 
IL-36 subfamily (7). However, the extent of expression of IL-36 
in healthy or infected uteri remains unknown. Most studies on 
members of the IL-36 family have focused on chronic inflam-
matory disorders, such as general pustular psoriasis, rheumatoid 
arthritis, tubulointerstitial lesions, inflammation of brain tissue, 
airway inflammation, and gingivitis (7). IL-36α, β, and γ are 
expressed by several cell types, but epithelial cells (keratinocytes) 
are potent producers of these cytokines and, importantly, they 
are overexpressed in psoriatic skin lesions (8). Transgenic mice 
overexpressing IL-36 in skin show phenotypic lesions related 
to those observed in human psoriasis, which suggests a pro-
inflammatory role of these cytokines (9). Immune cells, such 
as DCs, macrophages, T helper (Th) cells, and granulocytes, are 
also important producers and responders to IL-36, and they also 
participate in pro-inflammatory diseases, such as psoriasis (10).
We explored the expression of IL-36 subfamily members in 
the uteri of pregnant mice infected and not infected by Listeria 
monocytogenes. Our results showed that these cytokines show dif-
ferential upregulation of expression during estrus, implantation, 
and labor, suggesting that members of the IL-36 subfamily have 
different functions in their pro-inflammatory roles. Our results 
contribute to understanding of the immunologic processes acti-
vated during reproduction.
MaTerials anD MeThODs
ethical approval of the study Protocol
Experiments were carried out according to the relevant guide-
lines for animal use as approved by the Institutional Bioethics 
Committee of Escuela Nacional de Ciencias Biológicas-IPN 
(Ciudad de México, Mexico). These guidelines are based on 
the Guide for the Care and Use of Laboratory Animals (National 
Institutes of Health, Bethesda, MD, USA).
Mating between non-infected Mice
Healthy, virgin, and sexually mature ICR female mice (8 weeks) 
were obtained from the Animal Center Facilities of Escuela 
Superior de Medicina-IPN (Mexico City, Mexico). Mice were 
housed in a room at constant temperature (22°C) with a fixed 
12-h light–dark cycle and had access to food and water ad libitum.
Stage of the estrous cycle was determined by cytologic evalu-
ation of vaginal smears. From mice with two continuous estrous 
cycles, uteri were collected at diestrus, proestrus, estrus, and 
metestrus (n = 4 mice per stage).
Healthy female mice at the estrus stage were mated with 
healthy C57BL/6 male mice overnight. The following morning, 
spermatozoids in females were verified with a vaginal smear and, 
if spermatozoids were present, the mice were considered to be 
0.5 days post coitum (dpc).
Four uteri from pregnant mice were collected 4.5, 5.5, 7.5, and 
10.5 dpc (“peri-implantation” period); 12.5, 16.5, 18.5 dpc (“fetal 
development”); 19.5  dpc (“labor”); 2  days post-labor; 5  days 
post-labor. Uteri were extracted to measure the levels of mRNA 
and protein for IL-36 subfamily members. Samples were also 
embedded in paraffin for immunofluorescent analyses.
infection of BalB/c Mice with  
L. monocytogenes
A suspension of infective L. monocytogenes was prepared in 
sterile phosphate-buffered saline (PBS) at 109 CFU/mL. Female 
BALB/c mice were inoculated (i.v.) in the tail with 100 μL of the 
L. monocytogenes suspension (108 CFU/mouse) during estrus.
After infection, mice showed typical piloerection after day 3. 
Then, mice were again cycled and mated overnight with a healthy 
C57BL/6 male to obtain semiallogenic offspring. A procedure 
identical to that described above was carried out for non-infected 
mice to determine pregnancy. Implantation sites from pregnant 
non-infected and infected BALB/c mice were obtained at diestrus 
and at estrus, as well as at 4.5, 5.5, 7.5, and 10.5 dpc. To confirm 
infection with L. monocytogenes in harvested uteri, CFU/mL was 
determined, and a polymerase chain reaction (PCR) coupled to 
the DNA sequence of the 16S ribosome was carried out (data not 
shown).
semi-Quantitative reverse  
Transcription-Polymerase chain reaction
Uteri were homogenized individually, and RNA was isolated 
using TRIzol® reagent (Invitrogen, Carlsbad, CA, USA). Total 
RNA concentration was evaluated using a NanoDrop spectropho-
tometer (Thermo Scientific, Wilmington, DE, USA). Total RNA 
(2 μg) was reacted with DNAse I (Affymetrix, Santa Clara, CA, 
USA). cDNA was synthesized using MLV reverse transcriptase 
(Invitrogen). PCR reactions (20 μL) were carried out using 1 μL 
of the cDNA reaction, 10 μL of AmpliTaq Gold® Fast PCR Master 
Mix (Life Technologies, Gaithersburg, MD, USA), and 0.2 μM-
each of IL-36R, IL-36α, IL-36β, IL-36γ, and IL-36Ra primers 
TaBle 1 | sequences of oligonucleotides.
gene/mouse sequence
GAPDH FWD: 5′-CTACCCCCAATGTGTCCGTC-3′
REV: 5′-GCCGTATTCATTGTCATACCAGG-3′
IL-36α FWD: 5′-CATGGATCCTCACAATCTCCCA-3′
REV: 5′-ACTTCCTTAAGCGCAAAGTTGG-3′
IL-36β FWD: 5′-CATGGATCCTCACAATCTCCCA-3′
REV: 5′-GCGCAAAGTTGGTTTGCCC-3′
IL-36γ FWD: 5′-ACACCCATTTTCTACACACATCT-3′
REV: 5′-AGCAGCAAAGTAGGGTGTCC-3′
IL-36R FWD: 5′-GCAGCAGATACGTGTGAGGAC-3′
REV: 5′-TTGGTAGCAGTTGTGGGCATT-3′
IL-36Ra FWD: 5′-GGGCACTATGCTTCCGAATG-3′
REV: 5′-CTTTGATTCCTGGCCCCCGA-3′
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or the glyceraldehyde 3-phosphate dehydrogenase (GAPDH) 
primer (housekeeping gene) (Table  1). Optimized PCR condi-
tions were 35 cycles at 96°C for 5 s, 60°C for 5 s, and 68°C for 5 s. 
Amplified DNA (250 bp) was analyzed on a 2% agarose gel and 
stained using RedGel (Biotium Inc., CA, USA). Gel images were 
acquired in a ChemiDoc-It™ transilluminator (UVP, Upland, 
CA, USA), and the integrated pixel density (PD) of each band 
was calculated using AlphaImager® (ProteinSimple, San Jose, CA, 
USA). The PD of each gene band was normalized by dividing 
the PD of the sample by that of the corresponding housekeeping 
gene (GAPDH) band. The change in the expression of each gene 
was calculated by dividing the expression of the normalized gene 
at a specified point in pregnancy by that of the expression of the 
normalized gene at diestrus.
Western Blotting
A total protein fraction (coming from 3 implantation sites or 
1/2 uterus from non-pregnant mice) was extracted from uteri 
using 400 μL of RIPA buffer [Tris-HCl (pH 7.6), NaCl (150 mM), 
EDTA (2  mM), glycerol (10%), Triton-X100 (1%), sodium 
desoxicolate (0.5%), sodium lauryl sulfate (0.2%)], 1  mM of 
phenylmethylsulfonyl fluoride (Sigma–Aldrich, Saint Louis, 
MO, USA), and 1× complete protease inhibitor cocktail (Roche 
Diagnostics, Mannheim, Germany). Proteins were quantified 
using the Lowry method (Bio-Rad Laboratories, Hercules, CA, 
USA); 25  μg of protein extract were diluted 1:5 in Laemmli 
sample buffer (Bio-Rad Laboratories) containing 2-mercaptoe-
thanol (Bio-Rad) and denatured by boiling. Samples were loaded 
on SDS–PAGE 15% gels and transferred to cellulose sheets 
(Amersham Biosciences, Amersham, UK). Non-specific binding 
was blocked with 4% gelatin in PBS 1× containing 0.5% Tween-
20 for 1 h at 37°C. Specific primary antibodies to polyclonal goat 
anti-IL-36α, anti-IL-36β, anti-IL-36γ, anti-IL-36R, and anti-IL-
36Ra (Santa Cruz Biotechnology, Santa Cruz, CA, USA) were 
diluted 1:750 in blocking buffer. The secondary antibody was 
horseradish peroxidase–IgG mouse anti-goat (1:5000 dilution). 
Chemiluminescence was developed using an electrochemilu-
minescence western blotting substrate (Pierce Biotechnology, 
Waltham, MA, USA) and detected on a ChemiDoc™ Touch 
imaging system (Bio-Rad).
immunofluorescence assay
Uteri were fixed in 4% formalin and embedded in paraffin. 
Tissue slices (thickness, 6 μm) were obtained using a microtome 
(RM2125RT; Leica, Wetzlar, Germany) and placed on slides 
pre-coated with poly-l-lysine. Antigen retrieval was achieved 
by heating in a pressure cooker at 95°C for 15  min followed 
by immersion in antigen retrieval buffer (Life Technologies, 
Carlsbad, CA, USA). Samples were blocked with 0.1% albumin 
solution and incubated with primary antibody (anti-IL-36α, anti-
IL-36β, anti-IL-36γ, anti-IL-36R, or anti-IL-36Ra) diluted in PBS 
for 50  min at 37°C. After two washes, the secondary antibody 
(rabbit fluorescein isothiocyanate–IgG anti-goat IgG) was added 
to samples at 1:1500 dilution and incubated for 1  h at 37°C. 
Preparations were observed under a confocal microscope (LSM 
700; Zeiss, Oberkochen, Germany) for image capture. Captures 
were analyzed using LSM v5 Image Examiner software (Zeiss).
statistical analyses
Results are the mean ±  SEM. Statistical analyses were carried 
out using GraphPad Prism (GraphPad, San Diego, CA, USA). 
Differences between samples were evaluated using Newman–
Keuls multiple comparison tests, after one-way ANOVA. p ≤ 0.05 
was considered significant.
resUlTs
expression of il-36 subfamily Members  
in non-infected Uteri during  
the estrous cycle
The mRNA expression of IL-36α, β, and γ (Figures  1A–C, 
respectively) and the corresponding production of proteins 
(Figures 2A–C, respectively) were similar to those of other pro-
inflammatory cytokines in the estrous cycle. That is, expression 
occurred at diestrus, increased slightly at proestrus, reached maxi-
mal expression at estrus, decreased at metestrus, was again lowest 
at diestrus, and then the cycle started again (Figures 1A–C). It 
was found that mRNA (Figure 1D) and protein (Figure 2E) levels 
of IL-36R, which behaved as agonists during the estrous cycle, 
showed maximal expression at estrus, declined at metestrus, 
and then was reduced to the baseline level at diestrus. IL-36Ra 
showed a different expression behavior than the other subfam-
ily members: mRNA (Figure 1E) and protein (Figure 2F) were 
present mainly at proestrus rather than at estrus; and at estrus 
and metestrus, expression was even lower than that at proestrus.
il-36 subfamily Members  
in embryo implantation
Embryo implantation is a crucial event for mammals, and inflam-
matory cytokines are involved. Here, we investigated whether 
IL-36 subfamily members are involved in implantation.
At the start of implantation, IL-36α expression remained at 
similar levels at metestrus and decreased at the end of implanta-
tion (Figures  1A and 2B). IL-36β expression increased at the 
beginning of implantation (4.5 dpc) and decreased progressively 
until 10.5 dpc, and even at 7.5 and 10.5 dpc, the protein could 
FigUre 1 | mrna expression of il-36 family members in non-pregnant and pregnant mice. IL-36α (a), β (B), γ (c), IL-36R (D), and IL-36Ra (e). mRNA 
levels are expressed as fold increases normalized to GAPDH and relative to diestrus of non-infected mice. PCR results are shown as the mean ± SE. *p ≤ 0.05, 
**p ≤ 0.01, ***p ≤ 0.001 for significant difference between groups. d, diestrus; p, proestrus; e, estrus; m, metestrus; dpc, days post coitum; L, labor; dpl, days 
post-labor. n = 4.
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FigUre 2 | Protein analyses of il-36 (α, β, and γ), il-36r, and il-36ra. 
Uterus extracts were tested with antibodies against IL-36α, β, γ, IL-36R, and 
IL-36Ra. Actin was used as a loading control. (a) Western blot of 
representative data from four individuals. (B–F) Protein levels are expressed 
as fold increases normalized to GAPDH and relative to diestrus. d, diestrus; 
p, proestrus; e, estrus; m, metestrus; dpc, days post coitum; L, labor; dpl, 
days post-labor.
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not be detected (Figure  2C). IL-36γ expression was barely 
detected at the beginning of implantation but had increased by 
11-fold at the end of implantation (10.5 dpc) (Figure 1C); IL-36γ 
protein showed identical behavior (Figure  2D). Expression 
of IL-36R mRNA remained similar during implantation but 
increased slightly at 5.5 dpc (Figure 1D). However, expression of 
IL-36R protein increased at 5.5 and 7.5 dpc during implantation 
(Figure  2E). Expression of IL-36Ra increased noticeably after 
metestrus, reaching optimal expression at 5.5 dpc for mRNA and 
protein (Figures 1E and 2F).
il-36 subfamily Members in Fetal 
Development
At 12.5 dpc, protein expression of IL-36α, β, and γ was not detect-
able and increased progressively until labor. Expression of IL-36β 
mRNA increased considerably, but expression of the protein of 
IL-36α and γ increased even more (Figures 1E and 2F).
For IL-36R, mRNA expression remained at the same level as 
during implantation, but the protein increased considerably dur-
ing fetal development until labor (Figures 1E and 2F). Expression 
of IL-36Ra increased after 10.5  dpc, reaching optimal mRNA 
expression at 18.5 dpc, and decreased at labor (Figure 1E).
Behavior of il-36 Members after labor
After a considerable increase in expression at labor, expression of 
pro-inflammatory cytokines declined after childbirth to hormo-
nal-cycle levels. We also analyzed the behavior of IL-36 subfamily 
members after labor. Expression of all IL-36 agonists decreased 
significantly after labor. IL-36R was detected constantly during 
late pregnancy, even in labor, where production of IL-36 agonists 
was increased (Figure 1D), but that of their proteins decreased at 
5 dpc (Figure 2E). Expression of IL-36Ra was also downregulated 
after labor (Figures 1E and 2F).
immunolocalization of il-36  
in Uterine Tissues
Immunofluorescence detection of IL-36 subfamily members was 
undertaken. Diestrus showed a reduced presence of agonists 
distributed randomly in the luminal epithelium, glandular 
epithelium, and perimetrium. However, IL-36R and IL-36Ra 
showed a more concentrated presence in glandular and luminal 
epithelia (Figure 3). Western blotting revealed the presence of the 
three agonists to be increased during proestrus and estrus and, in 
these stages, IL-36α showed a characteristic distribution in the 
glandular epithelium, perimetrium, myometrium, and stratum 
vasculare. IL-36β and γ were distributed more homogenously, 
but spots in the glandular epithelium were not seen. IL-36R and 
IL-36Ra showed a similar pattern of distribution in diestrus, 
and they were detected in glandular and luminal epithelia, with 
increased detection in the perimetrium (Figure  3). At the end 
of the estrous cycle, during metestrus, detection of agonists and 
antagonists of IL-36 was diminished drastically compared with 
that at estrus, whereas IL-36R was maintained in the uterus 
(Figure 3).
Expression of the agonists, receptors, and antagonists of IL-36 
was localized by immunofluorescence in uterine tissues at early 
FigUre 3 | Pro-inflammatory il-36 agonists, il-36r and il-36ra are expressed mainly in endometrial and peri-myometrial tissue in the estrous 
cycle. ICR females were killed at each stage of the estrous cycle. Tissues slides were treated with goat anti-IL-36 (α, β, γ, R, and Ra) as primary antibody and 
anti-goat-FITC as secondary antibody. Immunofluorescence images were taken with a LSM 700 confocal microscope (Zeiss) and processed using LSM 5 Image 
Examiner software (Zeiss). Magnification = × 20. Myo, myometrium; LE, luminal epithelium; GE, glandular epithelium; Lu, lumen; SV, stratum vasculare; Pe, 
perimetrium.
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implantation (4.5  dpc), during the final phase of implantation 
(10.5  dpc), at culmination of pregnancy (labor), and at 2  days 
after labor (Figure  4). Similar to previous results, expression 
of IL-36α and IL-36β was higher than IL-36γ expression in the 
implantation period (4.5 dpc), and this expression was observed 
in the decidua. IL-36R showed low expression in the decidua and 
myometrium, as did IL-36Ra (Figure 4).
IL-36 subfamily members at 4.5 and 10.5  dpc showed a 
characteristic distribution as small spots close to blood vessels. 
At labor, expression of the five members of the IL-36 subfamily 
was upregulated (in accordance with western blotting results) 
and distributed alongside the interface between the luminal 
epithelium and placenta (Figure  4). Two days after labor, cells 
from luminal and glandular epithelia showed a large decrease in 
the production of IL-36 family members, except for moderate 
expression of IL-36Ra (Figure 4).
infection by Listeria monocytogenes 
induces severe Overexpression of il-36 
subfamily Members
We measured the expression of IL-36 subfamily members in a 
murine model of L. monocytogenes infection because infection 
with this pathogen induces an inflammatory response and can 
eventually cause fetal loss (11). The infection was established 
before pregnancy in order to ascertain whether the inflammatory 
response that occurs normally during implantation in healthy 
pregnancies would be modified due to L. monocytogenes.
Infection by L. monocytogenes reduced the number of 
implanted embryos (data not shown) and induced severe 
overexpression of IL-36 subfamily members compared with non-
infected mice (Figures 5 and 6). Notably, in the uteri of infected 
mice, the five members of the IL-36 subfamily showed increases in 
FigUre 4 | il-36 cytokines and il-36r localization in maternal–fetal tissues during pregnancy. ICR females were killed at each stage of pregnancy. 
Tissues slides were treated with goat anti-IL-36 (α, β, γ, R, and Ra) as primary antibody and anti-goat-FITC as secondary antibody. Immunofluorescence images 
were taken with a LSM 700 confocal microscope (Zeiss) and processed using LSM 5 Image Examiner software (Zeiss). Magnification = × 20 objective. DZ, decidua; 
Emb, embryo; Myo, myometrium; P, placenta; BV, blood vessels; E, endometrium; Lu, lumen; SV, stratum vasculare; Pe, perimetrium; LE, luminal epithelium; dpc, 
days post-coitums; dpl, days post-labor.
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mRNA expression between 25- and 150-fold higher as compared 
with expression in the implantation sites of non-infected mice at 
4.5, 5.5, and 7.5 dpc (Figure 5). Protein analyses revealed a clear 
increase in expression of IL-36 subfamily members (Figure 6), 
suggesting that they have a crucial role in the response against 
L. monocytogenes, and that the increased expression could be the 
cause of miscarriage or infertility (Figure 6).
DiscUssiOn
We found that the expression of IL-36 subfamily members in mice 
is regulated differently during pro-inflammatory stages in the 
estrous cycle and in pregnancy, and that they are induced severely 
by infection during pregnancy. When we evaluated the produc-
tion of IL-36 subfamily members in mice uteri during the estrous 
cycle, we found that IL-36 agonists showed a cyclic behavior 
similar to that observed for other inflammatory cytokines, such 
as IL-1β, TNFα, and IL-6 (12).
In early pregnancy, implantation is considered to be a funda-
mental period in which the fertilized egg must interact with the 
endometrial epithelium that, in turn, must be suitable to receive 
the product (13). This interaction is regulated strongly by an envi-
ronment rich in pro-inflammatory cytokines and growth factors 
that favor blastocyst implantation (14). In early pregnancy, we 
found that IL-36 subfamily members were produced in different 
patterns but coincided in their overexpression at estrus where, in 
the case of egg fertilization, the endometrium is ready for implan-
tation. IL-36α, β, and γ have been shown to induce the cytokine 
granulocyte-macrophage colony-stimulating factor (GM-CSF) 
in vitro in bone-marrow DCs (15). GM-CSF has been reported to 
be an important growth factor involved in embryo and placental 
development in early pregnancy (16).
FigUre 6 | Protein analyses of il-36 (α, β, and γ), il-36r, and il-36ra 
in uterus of mice infected with L. monocytogenes. Uterus extracts of 
non-infected and infected mice were analyzed using antibodies against 
IL-36α, β, γ, IL-36R, and IL-36Ra. Actin was used as a loading control.  
(a) Western blot of representative data from four individuals. (B–F) Protein 
levels are expressed as fold increases normalized to GAPDH and relative to 
diestrus of non-infected mice. e, estrus; dpc, days post coitum.
FigUre 5 | mrna expression of il-36 family members in uterus of 
infected mice with L. monocytogenes. IL-36α (a), β (B), γ (c), IL-36R 
(D), and IL-36Ra (e). mRNA levels are expressed as fold increases 
normalized to GAPDH and relative to diestrus of non-infected mice. PCR 
results are shown as the mean ± SE. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001 for 
significant differences between uninfected and infected groups. d, diestrus;  
e, estrus; dpc, days post-coitum. n = 4.
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During the final phase of pregnancy, the fetus has completed 
its development and is ready for birth. For labor, an influx of 
immune cells into the myometrium is needed to promote reversal 
of the inflammatory process. This pro-inflammatory environ-
ment promotes contraction of the uterus, expulsion of the fetus, 
and rejection of the placenta (17).
In healthy pregnancies, we found IL-36α, β, and γ to be highly 
expressed in labor. In this context, IL-36 has been reported to 
induce the expression of other pro-inflammatory cytokines, such 
as IL-1β, IL-6, TNF-α, IL-17, IL-23, IL-12, IL-8, prostaglandin-E2, 
cyclo-oxygenase-2, and interferon-γ (9, 15, 18). IL-36 also induces 
expression of chemokines, such as CXCL1, CCL1, CXCL10, 
CCL11, CCL4, CXCL2, CCL2, CXCL16, CCL7, and CCL20, 
along with a range of growth factors (GM-CSF, G-CSF, M-CSF, 
and VEGF) (19), and also metalloproteinases (MMP1, MMP9, 
MMP10, and MMP19) (20). Expression of most of these molecules 
is upregulated and has been described during parturition (21).
Finally, we measured the expression of IL-36 subfamily mem-
bers in mice infected with L. monocytogenes before pregnancy. 
L. monocytogenes is a Gram-positive bacterium that can grow and 
replicate within host cells and that can lead to infertility, spon-
taneous abortion, premature labor, meningitis, or stillbirth (11). 
We found that expression of the agonists IL-36α, β, and γ, IL-36R, 
and that of the antagonist IL-36RA increased by many fold in 
the uterine tissue of infected pregnant mice compared with non-
infected pregnant mice. IL-36 has been associated with a response 
to bacterial infections. For example, Medina-Contreras and 
coworkers reported that gut microbiota are involved specifically 
in IL-36γ expression, which is essential for the resolution of dam-
age induced by dextran sodium sulfate (DSS) (22). Segueni et al. 
showed that, in a model of systemic infection by Mycobacterium 
bovis attenuated after instillation of Bacillus Calmette–Guérin, 
IL-36γ expression was increased in the lungs of infected mice 
(23). Also, it has been shown that IL-36γ has a crucial role in 
the innate immune response to Klebsiella pneumoniae and 
Streptococcus pneumoniae infection, inducing Th-1 and Th-17 
immune responses (24).
Non-immune and immune cells, such as keratinocytes, 
fibroblasts, bronchial epithelial cells, DCs, macrophages, natural 
killer cells, CD4+ lymphocytes, and neutrophils, are important 
sources of IL-36 cytokines if they come into contact with certain 
pathogen-associated molecular patterns, and could be impor-
tant for the immune response against L. monocytogenes (25). 
Neutrophil-produced proteases, such as cathepsin G, elastase, 
and proteinase-3, are responsible for cleavage of IL-36α, β, γ and 
IL-36Ra to obtain active agonist or antagonist fractions (26, 27). 
Neutrophils are one of the first cell types in the innate immune 
system to respond, so it seems that processed IL-36 agonists have 
a critical role in the initial response to L. monocytogenes infec-
tion or tissue damage at the maternal–fetal interface. However, 
L. monocytogenes uses phagocytic cells for dissemination; we do 
not know the main cell type responsible for IL-36 production 
and whether the overproduction of IL-36 induced by L. mono-
cytogenes contributes to the elimination of this pathogen or to its 
dissemination toward fetal tissues.
In human gestational tissues, IL-36 expression has not been 
studied thoroughly. Only Southcombe et  al. have reported no 
differential expression of IL-36α, β, and γ in the placentas of 
women with healthy pregnancies compared with women with 
preeclampsia (28). However, they found lower production of 
IL-36Ra in the sera and placenta of women with preeclampsia 
compared with normal pregnancies (28). Our results suggest that 
the IL-36 system may have important roles for (i) progression 
of the estrous cycle; (ii) maintenance of the inflammatory state 
during embryo implantation; and (iii) successful labor.
cOnclUsiOn
We show, for the first time, differential IL-36 (α, β, γ, R, and Ra) 
mRNA expression and protein production profile in the repro-
ductive tract during the estrous cycle, pregnancy, and labor in 
healthy pregnancies of mice, and during embryo implantation 
in infected pregnant mice. IL-36 agonists showed a pattern of 
expression and production similar to that seen for other pro-
inflammatory cytokines reported previously.
aUThOr cOnTriBUTiOns
All authors listed, have made substantial, direct and intellectual 
contribution to the work, and approved it for publication.
acKnOWleDgMenTs
The authors thank all the staff of the Animal Care Facilities of 
Escuela Superior de Medicina, and especially to M. en C. Ma. 
Eugenia Aguilar Nájera for the supply of mice. We also thank 
Ana Federica Chávez Sánchez and Carmen Mondragón Huerta 
(Department of Medicine of FES-Iztacala UNAM) and M. en C. 
Erika Rosales Cruz for her expert support in immunohistochemi-
cal assays.
FUnDing
This work was supported by CONACyT (grant number 162129) 
and by the Instituto Politécnico Nacional (SIP-20151135, SIP-
20160135). JM-C received postgraduate scholarships from 
CONACyT and BEIFI-IPN. SR-M, JC-D, MC-D, SP-T, and ER-M 
are COFAA-IPN, EDI-IPN, and SNI-CONACyT Fellows. FG-C is 
a Cátedra CONACyT Research Fellow.
reFerences
1. McMaster MT, Newton RC, Dey SK, Andrews GK. Activation and distribution 
of inflammatory cells in the mouse uterus during the preimplantation period. 
J Immunol (1992) 148(6):1699–705. 
2. Yoshinaga K. Review of factors essential for blastocyst implantation for their 
modulating effects on the maternal immune system. Semin Cell Dev Biol 
(2008) 19(2):161–9. doi:10.1016/j.semcdb.2007.10.006 
3. Simón C, Valbuena D, Krüssel J, Bernal A, Murphy CR, Shaw T, et  al. 
Interleukin-1 receptor antagonist prevents embryonic implantation by a 
10
Murrieta-Coxca et al. IL-36 Subfamily Members Are Involved in Pregnancy
Frontiers in Immunology | www.frontiersin.org September 2016 | Volume 7 | Article 376
direct effect on the endometrial epithelium. Fertil Steril (1998) 70(5):896–906. 
doi:10.1016/S0015-0282(98)00275-1 
4. Mor G, Cardenas I, Abrahams V, Guller S. Inflammation and pregnancy: the 
role of the immune system at the implantation site. Ann N Y Acad Sci (2011) 
1221(1):80–7. doi:10.1111/j.1749-6632.2010.05938.x 
5. Thomson AJ, Telfer JF, Young A, Campbell S, Stewart CJ, Cameron IT, 
et  al. Leukocytes infiltrate the myometrium during human parturition: 
further evidence that labour is an inflammatory process. Hum Reprod (1999) 
14(1):229–36. doi:10.1093/humrep/14.1.229 
6. Khan RN, Hay DP. A clear and present danger: inflammasomes DAMPing 
down disorders of pregnancy. Hum Reprod Update (2015) 21(3):388–405. 
doi:10.1093/humupd/dmu059 
7. Gabay C, Towne JE. Regulation and function of interleukin-36 cytokines in 
homeostasis and pathological conditions. J Leukoc Biol (2015) 97(4):RI1014–
495. doi:10.1189/jlb.3RI1014-495R 
8. Towne JE, Sims JE. IL-36 in psoriasis. Curr Opin Pharmacol (2012) 12(4):486–
90. doi:10.1016/j.coph.2012.02.009 
9. Blumberg H, Dinh H, Trueblood ES, Pretorius J, Kugler D, Weng N, et  al. 
Opposing activities of two novel members of the IL-1 ligand family regu-
late skin inflammation. J Exp Med (2007) 204(11):2603–14. doi:10.1084/
jem.20070157 
10. Torales-Cardeña A, Martínez-Torres I, Rodríguez-Martínez S, Gómez-
Chávez FG, Cancino-Díaz JC, Vázquez-Sánchez EAV, et al. Cross talk between 
proliferative, angiogenic, and cellular mechanisms orchestred by HIF-1α in 
psoriasis. Mediators Inflamm (2015) 2015(4):11. doi:10.1155/2015/607363
11. Hamon M, Bierne H, Cossart P. Listeria monocytogenes: a multifaceted model. 
Nat Rev Microbiol (2006) 4(6):423–34. doi:10.1038/nrmicro1413 
12. Sierra-Mondragón E, Gómez-Chávez F, Murrieta-Coxca M, Vázquez-Sánchez 
EA, Martínez-Torres I, Cancino Diaz ME, et al. Low expression of IL-6 and 
TNF-α correlates with the presence of the nuclear regulators of NF-κB, IκBNS 
and BCL-3, in the uterus of mice. Mol Immunol (2015) 68(2, Pt A):333–40. 
doi:10.1016/j.molimm.2015.09.020 
13. Aplin JD. Adhesion molecules in implantation. Rev Reprod (1997) 2(2):84–93. 
doi:10.1530/ror.0.0020084 
14. Kruse N, Greif M, Moriabadi NF, Marx L, Toyka KV, Rieckmann P. Variations 
in cytokine mRNA expression during normal human pregnancy. Clin Exp 
Immunol (2000) 119(2):317–22. doi:10.1046/j.1365-2249.2000.01123.x 
15. Vigne S, Palmer G, Lamacchia C, Martin P, Talabot-Ayer D, Rodriguez E, et al. 
IL-36R ligands are potent regulators of dendritic and T cells. Blood (2011) 
118(22):5813–23. doi:10.1182/blood-2011-05-356873 
16. Robertson SA. GM-CSF regulation of embryo development and preg-
nancy. Cytokine Growth Factor Rev (2007) 18(3–4):287–98. doi:10.1016/ 
j.cytogfr.2007.04.008 
17. Romero R, Espinoza J, Gonçalves LF, Kusanovic JP, Friel LA, Nien JK. 
Inflammation in preterm and term labour and delivery. Semin Fetal Neonatal 
Med (2006) 11(5):317–26. doi:10.1016/j.siny.2006.05.001 
18. Carrier Y, Ma HL, Ramon HE, Napierata L, Small C, O’Toole M, et  al. 
Inter-regulation of Th17 cytokines and the IL-36 cytokines in  vitro and 
in  vivo: implications in psoriasis pathogenesis. J Invest Dermatol (2011) 
131(12):2428–37. doi:10.1038/jid.2011.234 
19. Mutamba S. Investigation of the Expression and Biological Response of 
the IL-1Rrp2 Receptor in Human Cells. Nottingham, UK: University of 
Nottingham; Nottingham eTheses  (2012).
20. Foster AM, Baliwag J, Chen CS, Guzman AM, Stoll SW, Gudjonsson JE, et al. 
IL-36 promotes myeloid cell infiltration, activation, and inflammatory activity 
in skin. J Immunol (2014) 192(12):6053–61. doi:10.4049/jimmunol.1301481 
21. Gomez-Lopez N, StLouis D, Lehr MA, Sanchez-Rodriguez EN, Arenas-
Hernandez M. Immune cells in term and preterm labor. Cell Mol Immunol 
(2014) 11(6):571–81. doi:10.1038/cmi.2014.46 
22. Medina-Contreras O, Harusato A, Nishio H, Flannigan KL, Ngo V, Leoni G, 
et al. Cutting edge: IL-36 receptor promotes resolution of intestinal damage. 
J Immunol (2016) 196(1):34–8. doi:10.4049/jimmunol.1501312 
23. Segueni N, Vigne S, Palmer G, Bourigault ML, Olleros ML, Vesin D, et  al. 
Limited contribution of IL-36 versus IL-1 and TNF pathways in host response 
to mycobacterial infection. PLoS One (2015) 10(5):e0126058. doi:10.1371/
journal.pone.0126058 
24. Kovach MA, Newstead MW, Zeng X, Peters-Golden M, Standiford TJ. IL-36γ 
Is a potent inducer of type I and IL-17 cytokine induction during lung 
infection. American Thoracic Society International Conference Abstracts. 
Denver, CO: American Thoracic Society (2015). p. A6148.
25. Chustz RT, Nagarkar DR, Poposki JA, Silvio Favoreto J, Avila PC, Schleimer RP, 
et al. Regulation and function of the IL-1 family cytokine IL-1F9 in human 
bronchial epithelial cells. Am J Respir Cell Mol Biol (2012) 45(1):145–53. 
doi:10.1165/rcmb.2010-0075OC 
26. Macleod T, Doble R, McGonagle D, Wasson CW, Alase A, Stacey M, et  al. 
Neutrophil elastase-mediated proteolysis activates the anti-inflammatory 
cytokine IL-36 receptor antagonist. Sci Rep (2016) 6:24880. doi:10.1038/
srep24880 
27. Henry CM, Sullivan GP, Clancy DM, Afonina IS, Kulms D, Martin  SJ. 
Neutrophil-derived proteases escalate inflammation through activation 
of IL-36 family cytokines. Cell Rep (2016) 14(4):708–22. doi:10.1016/ 
j.celrep.2015.12.072 
28. Southcombe JH, Redman CWG, Sargent IL, Granne I. Interleukin-1 family 
cytokines and their regulatory proteins in normal pregnancy and  pre-eclampsia. 
Clin Exp Immunol (2015) 181(3):480–90. doi:10.1111/cei.12608 
Conflict of Interest Statement: All authors declare no conflict of interests, 
including any financial, personal, or other relationships with other people or 
organizations that could influence (or be perceived to influence) the results in an 
inappropriate manner.
Copyright © 2016 Murrieta-Coxca, Gómez-Chávez, Baeza-Martínez, Cancino-
Diaz, Cancino-Diaz, Pérez-Tapia, Reyes-Maldonado and Rodríguez-Martínez. 
This is an open-access article distributed under the terms of the Creative Commons 
Attribution License (CC BY). The use, distribution or reproduction in other forums 
is permitted, provided the original author(s) or licensor are credited and that the 
original publication in this journal is cited, in accordance with accepted academic 
practice. No use, distribution or reproduction is permitted which does not comply 
with these terms.
